Annovis Bio ANVS Q1 2026 Earnings EPS Miss Widens as Pipeline Costs Mount Stock Declines BMBL Q1 2026 Earnings EPS Beat Drives Slight Stock Uptick as User Trends Remain in Focus ELVN Q1 2026 Earnings NarrowerthanExpected Loss as PreRevenue Biotech Advances Pipeline JKS Q4 2025 Earnings Significant EPS Miss Despite Modest Share Gain ARTL Q4 2025 Earnings NarrowerThanExpected Loss Despite Zero Revenue STT Q1 2026 Earnings Strong EPS Beat Amid Market Uncertainty